Epidermal growth factor in gastric ulcer healing by nocloprost, a stable prostaglandin E2 derivative

Scandinavian Journal of Gastroenterology

Volumn 32, Issue 10, 1997, Pages 980-984

  Konturek, J W ^a   Hengst, K ^b   Konturek, S J ^b   Domschke, W ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b NONE

Author keywords

Epidermal growth factor; Gastric ulcer healing; Prostaglandins; Ranitidine

Indexed keywords

EPIDERMAL GROWTH FACTOR; NOCLOPROST; PROSTAGLANDIN E2 DERIVATIVE; RANITIDINE; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SALIVA LEVEL; STOMACH MUCOSA; STOMACH ULCER; TISSUE LEVEL; ULCER HEALING;

EID: 0030749009     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529709011213     Document Type: Article

References (21)

1. Howden CW, Jones DB, Peace KE. The treatment of gastric ulcer with antisecretory drugs. Relationship of pharmacological effect to healing rates. Dig Dis Sci 1988;33:619-24.
2. Vantrappen GJ, Jansens P, Popiela T, Kulig J, Tytgat GN, Huibregtse K, et al. Effect of 15(r)-15-methyl prostaglandin E (Arbaprostil) on the healing of duodenal ulcer. Gastroenterology 1982;83:357.
3. Hawkey CJ. Prostaglandins and mucosal protection: laboratory evidence versus clinical performance. In: Gardner A, Whittle BJR, editors. Advances in drug therapy of gastrointestinal ulcerations. Chichester: Wiley and Sons; 1989. p. 89-98.
4. Bianchi Porro G, Parente F. Prostaglandins as treatment for peptic ulcer: an overview of worldwide clinical experience. In: Bianchi Porro G, Dajani EZ, editors. Amsterdam: Cortina International; 1985. p. 39-51.
5. Konturek SJ, Radecki T, Brzozowski T, Gryglewski R. Gastric cytoprotection by epidermal growth factor. Role of endogenous prostaglandins and DANN synthesis. Gastroenterology 1981;81:438-45.
6. 2. Scand J Gastroenterol 1981;16:647-52.
7. Dajani EZ, Agrawal NM. Prevention and treatment of ulcers induced ny non-steroidal anti-inflammatory drugs: an update. J Physiol Pharmacol 1995;46:316-9.
8. Konturek SJ, Konturek JW, Kwiecien N, Obtulowicz W, Oleksy J, Hebzda Z, et al. Gastric protection by nocloprost against aspirin damage in humans. Possible role of epidermal growth factor. Scand J Gastroenterol 1991;26:231-6.
9. Siegmund W, Zschiesche M, Franke G, Amon I. Effects of nocloprost clathrate on absorption of acetylsalicylic acid. Int J Clin Pharmacol Ther 1994;32:51-7.
10. 2 analog: significant reduction of aspirin-induced gastric lesions in man. Prog Clin Biol Res 1987;241:295-8.
11. Calabro A, Milano S, Paladini I, Orsini B, Salvadori G, Surrenti C. Role of epidermal growth factor in peptic ulcer healing. Dig Dis Sci 1995;40:2497-504.
12. Konturek JW, Bielanski W, Konturek SJ, Bogdal J, Oleksy J. Distribution and release of epidermal growth factor in man. Gut 1989;30:1194-200.
13. Ohmura E, Emoto N, Tsushima T, Watanabe S, Takeuchi T, Kawamura M. Salivary immunoreactive human epidermal growth factor (IR-hEGF) in patients with peptic ulcer disease. Hepatogastroenterology 1987;34:160-3.
14. Calabro A, Orsini B, Brocchi A, Falchini M, Fedi P, Surrenti C. Gastric juice immunoreactive epidermal growth factor levels in patients with peptic ulcer disease. Am J Gastroenterol 1990;85:404-7.
15. Sakamoto C, Matsuda K, Nakano O, Konda Y, Matozaki T, Nishisaki H, et al. EGF stimulates both cyclooxygenase activity and cell proliferation of cultured guinea pig gastric mucous cells. J Gastroenterol 1994;29:73-6.
16. Kelly SM, Jenner JR, Dickinson RJ, Hunter JO. Increased gastric juice epidermal growth factor after non-steroidal anti-inflammatory drug ingestion. Gut 1994;35:611-4.
17. Gilchrist W, Burkhalter E, Eaton C, Schaudies RP, Maydonovitch C, Andrada F, et al. The effect of indomethacin on the secretion of human salivary epidermal growth factor. Am J Gastroenterol 1994;89:97-100.
18. Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active gastritis. Lancet 1983;1:1273-5.
19. Calam J Helicobacter pylori. London: Chapman and Hall Medical; 1996.
20. Itoh M, Matsuo Y. Gastric ulcer treatment with intravenous human epidermal growth factor: a double blind controlled clinical study. J Gastroenterol Hepatol 1994;9 Suppl:S78-83.
21. Konturek PC, Ernst H, Konturek J, Bobrzynski A, Kwiecien N, Faller G, et al. Salivary and gastric luminal release of epidermal growth factor under basal conditions and after pentagastrin stimulation in healthy subjects and in duodenal ulcer patients before and after eradication of Helicobacter pylori. J Physiol Pharmacol 1996;47:187-94.